{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:42:11Z","timestamp":1792201331071,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41433-026-04757-x","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:40:12Z","timestamp":1785321612000},"page":"2438-2445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Photobiomodulation therapy for children\u2019s eye and vision conditions"],"prefix":"10.1038","volume":"40","author":[{"given":"Alicia","family":"Fothergill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9261-2386","authenticated-orcid":false,"given":"Charles","family":"Hennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desta","family":"Bokre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7402-4350","authenticated-orcid":false,"given":"Annegret H.","family":"Dahlmann-Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"4757_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jphotobiol.2017.04.014","volume":"170","author":"SR Tsai","year":"2017","unstructured":"Tsai SR, Hamblin MR. Biological effects and medical applications of infrared radiation. J Photochem Photobio B. 2017;170:197\u2013207.","journal-title":"J Photochem Photobio B"},{"key":"4757_CR2","doi-asserted-by":"crossref","unstructured":"Hamblin MR, Demidova TN. Mechanisms of low level light therapy. Proc SPIE. 2006;6140:614001.","DOI":"10.1117\/12.646294"},{"key":"4757_CR3","unstructured":"MeSH Browser, Low-Level Light Therapy [MeSH descriptor D028022]. U.S. National Library of Medicine. Available at: https:\/\/meshb.nlm.nih.gov\/record\/ui?ui=D028022. Access Date October 2024."},{"key":"4757_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/pho.2015.9848","volume":"33","author":"JJ Anders","year":"2015","unstructured":"Anders JJ, Lanzafame RJ, Arany PR. Low-level light\/laser therapy versus photobiomodulation therapy. Photomed Laser Surg. 2015;33:183\u20134.","journal-title":"Photomed Laser Surg"},{"key":"4757_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-024-00569-x","volume":"10","author":"TNO Rassi","year":"2024","unstructured":"Rassi TNO, Barbosa LM, Pereira S, Novais EA, Penha F, Roisman L, et al. Photobiomodulation efficacy in age-related macular degeneration: a systematic review and meta-analysis of randomized clinical trials. Int J Retin Vitreous. 2024;10:54.","journal-title":"Int J Retin Vitreous"},{"key":"4757_CR6","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Gonz\u00e1lez MC, Ballesteros-S\u00e1nchez A, S\u00e1nchez-Gonz\u00e1lez J-M, Gargallo-Mart\u00ednez B. Intense pulse light combined with low-level light therapy in dry eye disease: A systematic review. Eye & Contact Lens: Science & Clinical Practice, 2022;49:8\u201313.","DOI":"10.1097\/ICL.0000000000000958"},{"key":"4757_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/neu.2022.0140","volume":"40(3-4)","author":"AR Stevens","year":"2023","unstructured":"Stevens, AR, Hadis M, Milward M, Ahmed, Z, Belli A, Palin W, et al. Photobiomodulation in acute traumatic brain injury: a systematic review and meta-analysis. J Neurotrauma. 2023;40:210\u201327.","journal-title":"J Neurotrauma"},{"key":"4757_CR8","first-page":"CD014758","volume":"2","author":"JG Lawrenson","year":"2023","unstructured":"Lawrenson JG, Shah R, Huntjens B, Downie LE, Virgili G, Dhakal R, et al.\u00a0\u00a0Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;2:CD014758.","journal-title":"Cochrane Database Syst Rev"},{"key":"4757_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169:467\u201373.","journal-title":"Ann Intern Med"},{"key":"4757_CR10","doi-asserted-by":"publisher","unstructured":"Fothergill A, Hennings C, Bokre D, Dahlmann-Noor A. Scoping Review Protocol: Uses of photobiomodulation in paediatric ophthalmology. 2025. https:\/\/doi.org\/10.17605\/OSF.IO\/H4JW2.","DOI":"10.17605\/OSF.IO\/H4JW2"},{"key":"4757_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaophthalmol.2023.1548","volume":"141","author":"H Liu","year":"2023","unstructured":"Liu H, Yang Y, Guo J, Peng J, Zhao P. Retinal damage after repeated low-level red-light laser exposure. JAMA Ophthalmol. 2023;141:693\u20135.","journal-title":"JAMA Ophthalmol"},{"key":"4757_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamaophthalmol.2024.5977","volume":"143","author":"YX Wang","year":"2025","unstructured":"Wang YX, Wang N, Wong TY. Red light therapy for myopia-current regulatory changes in China. JAMA Ophthalmol. 2025;143:197\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"4757_CR13","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/jamaophthalmol.2025.0835","volume":"143","author":"X Liao","year":"2025","unstructured":"Liao X, Yu J, Fan Y, Zhang Y, Li Y, Li X, et al. Cone density changes after repeated low-level red light treatment in children with myopia. JAMA Ophthalmol. 2025;143:480\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"4757_CR14","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1001\/jamaophthalmol.2024.0801","volume":"142","author":"K Cao","year":"2024","unstructured":"Cao K, Tian L, Ma DL, Zhao SQ, Li A, Jin ZB. Daily low-level red light for spherical equivalent error and axial length in children with myopia: a randomized clinical trial. JAMA Ophthalmol. 2024;142:560\u20137.","journal-title":"JAMA Ophthalmol"},{"key":"4757_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00417-022-05794-4","volume":"261","author":"H Chen","year":"2023","unstructured":"Chen H, Wang W, Liao Y, Zhou W, Li Q, Wang J. Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol. 2023;261:575\u201384.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4757_CR16","doi-asserted-by":"crossref","unstructured":"Chen Y, Xiong R, Chen X, Zhang J, Bulloch G, Lin X. Efficacy comparison of repeated low-level red light and low-dose atropine for myopia control: a randomized controlled trial. Transl Vis Sci Technol. 2022;11:33.","DOI":"10.1167\/tvst.11.10.33"},{"key":"4757_CR17","doi-asserted-by":"crossref","unstructured":"Zhang H, Song D, Wei R. The efficacy and safety of combination therapy of repeated low-level red light and defocus-incorporated multiple segments spectacle lenses for myopia control in children: the study protocol for a 12-month, randomized, parallel-controlled, and single-center clinical trial. Trials. 2024;25:514.","DOI":"10.1186\/s13063-024-08210-w"},{"key":"4757_CR18","doi-asserted-by":"crossref","unstructured":"Deen N, Zhu Z, Qi Z, Aung YYM, Bulloch G, Miao D, et al. Three-Month interim analyses of repeated low-level red-light therapy in myopia control in schoolchildren: a pilot multi-ethnic randomized controlled trial. Ophthalmic Epidemiol. 2026;33:266\u201374.","DOI":"10.1080\/09286586.2025.2500020"},{"key":"4757_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","volume":"130","author":"J Dong","year":"2023","unstructured":"Dong J, Zhu Z, Xu H, He M. \u00a0Myopia control effect of repeated low-level red-light therapy in chinese children: a randomized, double-blind, controlled clinical trial. Ophthalmology. 2023;130:198\u2013204.","journal-title":"Ophthalmology"},{"key":"4757_CR20","doi-asserted-by":"publisher","first-page":"e239612","DOI":"10.1001\/jamanetworkopen.2023.9612","volume":"6","author":"X He","year":"2023","unstructured":"He X, Wang J, Zhu Z, Xiang K, Zhang X, Zhang B. Effect of repeated low-level red light on myopia prevention among children in China with premyopia: a randomized clinical trial. JAMA Netw Open. 2023;6:e239612.","journal-title":"JAMA Netw Open"},{"key":"4757_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","volume":"129","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhu Z, Tan X, Kong X, Zhong H, Zhang J, et al.\u00a0Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial. Ophthalmology. 2022;129:509\u201319.","journal-title":"Ophthalmology"},{"key":"4757_CR22","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1159\/000529819","volume":"66","author":"ZH Lin","year":"2023","unstructured":"Lin ZH, Tao ZY, Kang ZF, Deng HW.\u00a0A study on the effectiveness of 650-nm red-light feeding instruments in the control of myopia. Ophthalmic Res. 2023;66:664\u201371.","journal-title":"Ophthalmic Res"},{"key":"4757_CR23","doi-asserted-by":"crossref","unstructured":"Liu G, Liu L, Rong H, Li L, Liu X, Jia Z, et al. Axial shortening effects of repeated low-level red-light therapy in children with high myopia: a multicenter randomized controlled trial. Am J Ophthalmol. 2025;270:203\u201315.","DOI":"10.1016\/j.ajo.2024.10.011"},{"key":"4757_CR24","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1136\/bjo-2023-324260","volume":"108","author":"G Liu","year":"2024","unstructured":"Liu G, Rong H, Liu Y, Wang B, Du B, Song D, et al. Effectiveness of repeated low-level red light in myopia prevention and myopia control. Br J Ophthalmol. 2024;108:1299\u2013305.","journal-title":"Br J Ophthalmol"},{"key":"4757_CR25","doi-asserted-by":"publisher","first-page":"103938","DOI":"10.1016\/j.pdpdt.2023.103938","volume":"45","author":"L Liu","year":"2024","unstructured":"Liu L, Wang Y, Liu F, Yu X, Xie L, Tan S, et al.\u00a0Effects of repeated low-level red-light therapy on macular retinal thickness and microvascular system in children with myopia. Photodiagnosis Photodyn Ther. 2024;45:103938.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4757_CR26","doi-asserted-by":"crossref","unstructured":"Liu Z, Sun Z, Du B, Gou H, Wang B, Lin Z, et al. The effects of repeated low-level red-light therapy on the structure and vasculature of the choroid and retina in children with premyopia. Ophthalmol Ther. 2024;13:739\u201359.","DOI":"10.1007\/s40123-023-00875-x"},{"key":"4757_CR27","doi-asserted-by":"crossref","unstructured":"Xu Y, Cui L, Kong M, Li Q, Feng X, Feng K, et al. Repeated low-level red light therapy for myopia control in high myopia children and adolescents: a randomized clinical trial. Ophthalmology. 2024;131:1314\u201323.","DOI":"10.1016\/j.ophtha.2024.05.023"},{"key":"4757_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03427-4","volume":"24","author":"K Qiu","year":"2024","unstructured":"Qiu K, David C, Li Y, Lei Z, Tong L, Lin W. A retrospective study of cumulative absolute reduction in axial length after photobiomodulation therapy. BMC Ophthalmol. 2024;24:191.","journal-title":"BMC Ophthalmol"},{"key":"4757_CR29","first-page":"23","volume":"13","author":"L Shang","year":"2024","unstructured":"Shang L, Gao S, Wang W, Chang M, Ma N, Huang C, et al.\u00a0Comparison of changes in retinal vascular density and thickness after using low-level red light and 0.01% atropine in premyopic children. Transl. 2024;13:23.","journal-title":"Transl"},{"key":"4757_CR30","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.18240\/ijo.2023.10.22","volume":"16","author":"XH Tang","year":"2023","unstructured":"Tang XH, Yu MT, Hu Y, He MG, Yang X.\u00a0Axial length shortening in myopic children with Stickler syndrome after repeated low-level red-light therapy. Int J Ophthalmol. 2023;16:1712\u20137.","journal-title":"Int J Ophthalmol"},{"key":"4757_CR31","doi-asserted-by":"crossref","unstructured":"Torii H, Mori K, Okano T, Kondo S, Yang HY, Yotsukura E, et al. Short-term exposure to violet light emitted from eyeglass frames in myopic children: a randomized pilot clinical trial. J Clin Med. 2022;11:6000.","DOI":"10.3390\/jcm11206000"},{"key":"4757_CR32","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.62347\/DTLF6342","volume":"16","author":"G Wu","year":"2024","unstructured":"Wu G, Dai X, Tian J, Sun J. Efficacy of repeated low-level red-light therapy combined with optical lenses for myopia control in children and adolescents. Am J Transl Res. 2024;16:4903\u201311.","journal-title":"Am J Transl Res"},{"key":"4757_CR33","doi-asserted-by":"publisher","first-page":"8915867","DOI":"10.1155\/2021\/8915867","volume":"2021","author":"F Xiong","year":"2021","unstructured":"Xiong F, Mao T, Liao H, Hu X, Shang L, Yu L, et al.\u00a0Orthokeratology and low-intensity laser therapy for slowing the progression of myopia in children. Biomed Res Int. 2021;2021:8915867.","journal-title":"Biomed Res Int"},{"key":"4757_CR34","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.ophtha.2024.05.015","volume":"131","author":"R Xiong","year":"2024","unstructured":"Xiong R, Wang W, Tang X, He M, Hu Y, Zhang J, et al.\u00a0Myopia control effect of repeated low-level red-light therapy combined with orthokeratology: a multicenter randomized controlled trial. Ophthalmology. 2024;131:1304\u201313.","journal-title":"Ophthalmology"},{"key":"4757_CR35","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/ceo.14149","volume":"50","author":"R Xiong","year":"2022","unstructured":"Xiong R, Zhu Z, Jiang Y, Kong X, Zhang J, Wang W, et al.\u00a0Sustained and rebound effect of repeated low-level red-light therapy on myopia control: a 2-year post-trial follow-up study. Clin Exp Ophthalmol. 2022;50:1013\u201324.","journal-title":"Clin Exp Ophthalmol"},{"key":"4757_CR36","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ophtha.2022.10.002","volume":"130","author":"R Xiong","year":"2023","unstructured":"Xiong R, Zhu Z, Jiang Y, Wang W, Zhang J, Chen Y, et al.\u00a0Longitudinal changes and predictive value of choroidal thickness for myopia control after repeated low-level red-light therapy. Ophthalmology. 2023;130:286\u201396.","journal-title":"Ophthalmology"},{"key":"4757_CR37","doi-asserted-by":"publisher","first-page":"104267","DOI":"10.1016\/j.pdpdt.2024.104267","volume":"49","author":"Y Xiong","year":"2024","unstructured":"Xiong Y, Liao Y, Zhou W, Sun Y, Zhu M, Wang X.\u00a0Effectiveness of low-level red light for controlling progression of Myopia in children and adolescents. Photodiagnosis Photodyn Ther. 2024;49:104267.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4757_CR38","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.ophtha.2024.05.023","volume":"131","author":"Y Xu","year":"2024","unstructured":"Xu Y, Cui L, Kong M, Li Q, Feng X, Feng K, et al.\u00a0Repeated low-level red light therapy for myopia control in high myopia children and adolescents: a randomized clinical trial. Ophthalmology. 2024;131:1314\u201323.","journal-title":"Ophthalmology"},{"key":"4757_CR39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/APO.0000000000000618","volume":"12","author":"M Xuan","year":"2023","unstructured":"Xuan M, Zhu Z, Jiang Y, Wang W, Zhang J, Xiong R, et al.\u00a0Longitudinal changes in choroidal structure following repeated low-level red-light therapy for myopia control: secondary analysis of a randomized controlled trial. Asia Pac J Ophthalmol (Philos). 2023;12:377\u201383.","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"4757_CR40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000527787","volume":"66","author":"W Yang","year":"2023","unstructured":"Yang W, Lin F, Li M, Wei R, Zhou J, Zhou X.\u00a0Immediate effect in the retina and choroid after 650 nm low-level red light therapy in children. Ophthalmic Res. 2023;66:312\u20138.","journal-title":"Ophthalmic Res"},{"key":"4757_CR41","doi-asserted-by":"crossref","unstructured":"Yu M, Tang X, Jiang J, Zhou F, Wang L, Xiang C, et al. Axial length shortening after combined repeated low-level red-light therapy in poor responders of orthokeratology in myopic children. J Ophthalmol. 2024;2024:4133686.","DOI":"10.1155\/2024\/4133686"},{"key":"4757_CR42","doi-asserted-by":"crossref","unstructured":"Zhai Z, Jiang H, Wu Y, Yang P, Zhou S, Hong J. Safety and feasibility of low fluence intense pulsed light for treating pediatric patients with moderate-to-severe blepharitis. J Clin Med. 2022;11:3080.","DOI":"10.3390\/jcm11113080"},{"key":"4757_CR43","doi-asserted-by":"publisher","first-page":"104216","DOI":"10.1016\/j.pdpdt.2024.104216","volume":"47","author":"H Zhang","year":"2024","unstructured":"Zhang H, Cui M, Jie Y, Chen T, Kang M, Bai W, et al.\u00a0Efficacy of repeated low-level red-light therapy in the prevention and control of myopia in children. Photodiagnosis Photodyn Ther. 2024;47:104216.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4757_CR44","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1038\/s41598-023-30500-7","volume":"13","author":"L Zhou","year":"2023","unstructured":"Zhou L, Tong L, Li Y, Williams BT, Qiu K. \u00a0Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence. Sci Rep. 2023;13:3321.","journal-title":"Sci Rep."},{"key":"4757_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/opo.12939","volume":"42","author":"L Zhou","year":"2022","unstructured":"Zhou L, Xing C, Qiang W, Hua C, Tong L.\u00a0Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort. Ophthalmic Physiol Opt. 2022;42:335\u201344.","journal-title":"Ophthalmic Physiol Opt"},{"key":"4757_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ophtha.2023.08.020","volume":"131","author":"W Zhou","year":"2024","unstructured":"Zhou W, Liao Y, Wang W, Sun Y, Li Q, Liu S, et al.\u00a0Efficacy of different powers of low-level red light in children for myopia control. Ophthalmology. 2024;131:48\u201357.","journal-title":"Ophthalmology"},{"key":"4757_CR47","doi-asserted-by":"publisher","first-page":"104198","DOI":"10.1016\/j.pdpdt.2024.104198","volume":"47","author":"M Zhu","year":"2024","unstructured":"Zhu M, Liu Y, Fang D, Li M, Fu T, Yao K, et al.\u00a0Safety of repeated low-level red-light therapy for children with myopia. Photodiagnosis Photodyn Ther. 2024;47:104198.","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"4757_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/pho.2011.3089","volume":"30","author":"BT Ivandic","year":"2012","unstructured":"Ivandic BT, Ivandic T. Low-level laser therapy improves visual acuity in adolescent and adult patients with amblyopia. Photomed Laser Surg. 2012;30:167\u201371.","journal-title":"Photomed Laser Surg"},{"key":"4757_CR49","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.2147\/OPTH.S318674","volume":"15","author":"CH Lin","year":"2021","unstructured":"Lin CH, Lin HC, Chen CY, Lih CC. Effect of low-level laser irradiation on accommodation and visual fatigue. Clin Ophthalmol. 2021;15:3431\u20139.","journal-title":"Clin Ophthalmol"},{"key":"4757_CR50","first-page":"267","volume":"9","author":"M Vanzini","year":"2016","unstructured":"Vanzini M, Gallamini M. Amblyopia: can laser acupuncture be an option?. J acupunct. 2016;9:267\u201374.","journal-title":"J acupunct"},{"key":"4757_CR51","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1038\/s41598-024-54161-2","volume":"14","author":"J Jiang","year":"2024","unstructured":"Jiang J, Yang X, Du F, Zheng W, Yang Y.\u00a0Therapeutic effect of intense pulsed light on different types of chalazion in children. Sci Rep. 2024;14:3645.","journal-title":"Sci Rep."},{"key":"4757_CR52","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/lsm.23339","volume":"53","author":"C Qiao","year":"2021","unstructured":"Qiao C, Li L, Wang H, Zhao C, Ke L, Sen D, et al.\u00a0Adverse events of intense pulsed light combined with meibomian gland expression versus meibomian gland expression in the treatment of meibomian gland dysfunction. Lasers Surg Med. 2021;53:664\u201370.","journal-title":"Lasers Surg Med"},{"key":"4757_CR53","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2147\/OPTH.S225506","volume":"13","author":"K Stonecipher","year":"2019","unstructured":"Stonecipher K, Potvin R. Low level light therapy for the treatment of recalcitrant chalazia: A sample case summary. Clin Ophthalmol. 2019;13:1727\u201333.","journal-title":"Clin Ophthalmol"},{"key":"4757_CR54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4274\/tjo.galenos.2020.28924","volume":"51","author":"OMG Totuk","year":"2021","unstructured":"Totuk OMG, Kabadayi K, Ozkapi C, Aykan U. Efficacy of intense pulsed light treatment for moderate to severe acute blepharitis or blepharoconjunctivitis: A retrospective case series. Turkish J Ophthalmol. 2021;51:89\u201394.","journal-title":"Turkish J Ophthalmol"},{"key":"4757_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41390-019-0520-7","volume":"87","author":"AL Kent","year":"2020","unstructured":"Kent AL, Abdel-Latif ME, Cochrane T, Broom M, Dahlstrom JE, Essex RW, et al.\u00a0A pilot randomised clinical trial of 670 nm red light for reducing retinopathy of prematurity. Pediatr Res. 2020;87:131\u20136.","journal-title":"Pediatr Res"},{"key":"4757_CR56","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1249\/MSS.0000000000003364","volume":"56","author":"AM Taylor","year":"2024","unstructured":"Taylor AM, Mannix R, Zafonte RD, Whalen MJ, Meehan WP 3rd. A randomized, double-blind, placebo-controlled clinical trial evaluating transcranial photobiomodulation as treatment for concussion. Med Sci Sports Exerc. 2024;56:822\u20137.","journal-title":"Med Sci Sports Exerc"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04757-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04757-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:03:32Z","timestamp":1792199012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04757-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":56,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4757"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04757-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7903395\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Dahlmann-Noor has received honoraria for contributing to educational events and advisory boards from Santen, Novartis, Bayer, CooperVision, Zeiss, Thea, Essilor and Hoya. She served as principal or co-ordinating investigator for the NEVAKAR CHAMP, CHAMP-UK, OCUMENSION, MYOPIA-X and MODERATO clinical trials. She is the PI on two studies investigating the effect of red light on adult and children\u2019s eyes, and she is a director of Myolight Ltd. The other authors have no interest to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}